Latest News & Features
Americas
Just one pharma company is recognised in a report that lists the most world's most inventive countries and companies. 23 January 2026
Americas
A district court judge shuts down a Novartis rival from reopening validity and infringement arguments over an Entresto patent. 22 January 2026
Americas
New rankings from LSIPR’s sister title spotlight the firms and lawyers that are most successfully navigating the volatile world of trade secrets, from ‘prompt injections’ to billion-dollar retrials. 22 January 2026
Americas
From public use and foreign sales to the challenges of proving infringement, plant patents present unique legal opportunities—and pitfalls—for the agricultural industry, explain Bree Vculek, Gaby Longsworth, and Robert Millonig of Sterne Kessler. 22 January 2026
Careers
Orrick, Herrington & Sutcliffe adds senior litigators with experience in patent, trade secret, copyright, trademark, and commercial disputes across life sciences and technology. 22 January 2026
Americas
The court’s review of a high-profile dispute could offer clarity on a grey area for pharma companies and generic drug makers, but also prompt fresh questions. 21 January 2026
Asia
Magic Circle and major US firm among dealmakers who worked on the licensing agreement for a bispecific antibody candidate, marking another significant outbound licensing deal from China’s biopharma sector. 20 January 2026
Americas
An Israeli medical device company’s lawsuit claims Edwards knowingly infringed its heart-valve patent, raising new risks as the giant pursues growth beyond its core market. 19 January 2026
Careers
The team, known for pharmaceutical and biotechnology patent litigation—including Hatch-Waxman and BPCIA disputes—as well as trade secret and licensing matters, joins a rival US firm. 16 January 2026
Europe
A first-of-its-kind project by sister title WIPR aims to highlight the world’s leading in-house intellectual property counsel—and it needs your help. 16 January 2026